Utama › Gangguan Metabolik › Indiana
Kajian klinikal Gangguan Metabolik di Indiana
5 kajian untuk Gangguan Metabolik sedang mencari peserta di lokasi di Indiana.
Teks kajian rasmi (Bahasa Inggeris)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- MediSphere Medical Research Center, LLC, Evansville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07595549A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
- Indiana University School of Medicine University Hospital, Indianapolis
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06525636A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06419374Rare and Atypical Diabetes Network
- Indiana University, Indianapolis
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 14 Ogo 2025 · NCT05544266Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.